George P Browman
Overview
Explore the profile of George P Browman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
2325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Browman G, Vollmann J, Virani A, Schildmann J
Per Med
. 2018 May;
11(4):413-423.
PMID: 29783476
The evolving vision for personalized medicine (PM) implies a systems approach to the re-organization of healthcare and how we define the boundary between care and research. Calls for scaling PM...
2.
3.
Somerfield M, Bohlke K, Browman G, Denduluri N, Einhaus K, Hayes D, et al.
J Clin Oncol
. 2016 Jul;
34(26):3213-20.
PMID: 27382097
Since the beginning of its guidelines program in 1993, ASCO has continually sought ways to produce a greater number of guidelines while maintaining its commitment to using the rigorous development...
4.
Cressman S, Browman G, Hoch J, Kovacic L, Peacock S
Oncologist
. 2015 Jun;
20(7):729-36.
PMID: 26032135
Background: Scientific advances have led to the discovery of novel treatments with high prices. The cost to publicly fund high-cost drugs may threaten the sustainability of drug budgets in different...
5.
Browman G, Somerfield M, Lyman G, Brouwers M
Implement Sci
. 2015 Apr;
10:28.
PMID: 25880370
Background: Continuous escalation in methodological and procedural rigor for evidence-based processes in guideline development is associated with increasing costs and production delays that threaten sustainability. While health research methodologists are...
6.
7.
Brouwers M, Kho M, Browman G, Burgers J, Cluzeau F, Feder G, et al.
J Clin Epidemiol
. 2011 Dec;
65(5):526-34.
PMID: 22189163
Objective: To explore the role of a four-item Global Rating Scale (GRS) that could be used in place of the Appraisal of Guidelines, Research and Evaluation II (AGREE II). Study...
8.
Browman G, Manns B, Hagen N, Chambers C, Simon A, Sinclair S
J Oncol Pract
. 2010 Sep;
4(1):2-7.
PMID: 20859436
Purpose: To design a tool to assist clinician participation with cancer drug funding decisions. Public policy-makers and insurers are struggling with funding decisions regarding increasingly expensive new cancer drugs. Increasingly,...
9.
Brouwers M, Kho M, Browman G, Burgers J, Cluzeau F, Feder G, et al.
Prev Med
. 2010 Aug;
51(5):421-4.
PMID: 20728466
No abstract available.
10.
Brouwers M, Kho M, Browman G, Burgers J, Cluzeau F, Feder G, et al.
J Clin Epidemiol
. 2010 Jul;
63(12):1308-11.
PMID: 20656455
No abstract available.